[PIH49] Population Access to Rotavirus Vaccination in Developped Countries: Lessons Learned from Current Experience and Potential Implications for the Future
2012 Value in health
Toumi, M. | Aballea, S. | Millier, A. | Duvillard, R. |
In developed countries, rotavirus disease causes significant burden, both on health care systems and society. Two effective and well-tolerated rotavirus vaccines were marketed in Europe & USA in 2006. Since then, there have been significant discrepancies in policy decisions and health technology assessments (HTAs) relating to the inclusion of universal vaccination into national immunisation programmes, thereby causing unequal population access to rotavirus vaccination. This study aims to understand past HTAs and policy decisions concerning the recommendation, funding and implementation of universal rotavirus vaccination in developed countries.